Raymond James Financial Inc. Acquires Shares of 1,456,436 Colgate-Palmolive (NYSE:CL)

Raymond James Financial Inc. acquired a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,456,436 shares of the company's stock, valued at approximately $132,405,000. Raymond James Financial Inc. owned 0.18% of Colgate-Palmolive at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. D Orazio & Associates Inc. grew its position in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock valued at $297,000 after acquiring an additional 108 shares in the last quarter. Commonwealth Financial Services LLC boosted its stake in shares of Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after purchasing an additional 118 shares during the period. Lantz Financial LLC grew its holdings in Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock valued at $1,831,000 after purchasing an additional 122 shares in the last quarter. Horizon Kinetics Asset Management LLC increased its stake in Colgate-Palmolive by 4.2% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock worth $322,000 after buying an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc lifted its holdings in Colgate-Palmolive by 1.0% in the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock worth $1,182,000 after buying an additional 130 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

Several research firms recently commented on CL. Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. UBS Group decreased their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Monday, March 3rd. Barclays dropped their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research report on Friday, January 17th. Finally, Raymond James reaffirmed an "outperform" rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $101.61.

Colgate-Palmolive Stock Performance

Shares of CL traded down $2.42 during trading hours on Tuesday, reaching $95.09. 1,030,937 shares of the company's stock traded hands, compared to its average volume of 4,142,657. The business's fifty day simple moving average is $88.97 and its two-hundred day simple moving average is $95.06. The firm has a market capitalization of $77.16 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm earned $0.87 earnings per share. Analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's payout ratio is 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.